Marianne Sloss

This inventor holds 17 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 3 EPO patents. Top assignees: Signal Pharmaceuticals, Inc., Pharmacopeia Drug Discovery, Inc.. Active years: 2009-2024.

USPTO Granted Patents = 17 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 14.1

ph-index = 7

Forward Citations = 182(Granted Patents)

Company Filing History:

17 out of 169

Signal Pharmaceuticals, Inc.

patents

1 out of 52

Pharmacopeia Drug Discovery, Inc.

patents

where one patent can have more than one assignee

Years Active: 2009-2024

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12129237 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith (2024-10-29),

2. 11590139 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith (2023-02-28),

3. 11325890 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith (2022-05-10),

4. 10940152 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith (2021-03-09),

5. 10919865 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith (2021-02-16),

6. 10646493 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith (2020-05-12),

7. 10398700 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith (2019-09-03),

8. 10266500 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith (2019-04-23),

9. 10149849 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith (2018-12-11),

10. 10040770 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith (2018-08-07),

11. 9737541 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith (2017-08-22),

12. 9701643 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith (2017-07-11),

13. 9512124 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith (2016-12-06),

14. 9139534 - Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith (2015-09-22),

15. 8101588 - Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith (2012-01-24),

Title: The Innovative Journey of Marianne Sloss

Introduction

Marianne Sloss is a prominent inventor based in San Diego, California. She has made significant contributions to the field of pharmaceuticals, holding a total of 17 patents. Her work focuses on developing novel compounds and methods for treatment, showcasing her expertise and dedication to innovation.

Latest Patents

Among her latest patents are the "Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith." This patent highlights her development of diaminopyrimidine compounds with specific structures. Additionally, she has patented "Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith," which emphasizes her work on aminopurine compounds.

Career Highlights

Throughout her career, Marianne has worked with notable companies such as Signal Pharmaceuticals, Inc. and Pharmacopeia Drug Discovery, Inc. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Marianne has collaborated with esteemed colleagues, including Robert Hilgraf and Yoshitaka Satoh. These partnerships have further enriched her work and expanded her impact in the field of drug discovery.

Conclusion

Marianne Sloss exemplifies the spirit of innovation in the pharmaceutical industry. Her extensive patent portfolio and collaborative efforts highlight her commitment to advancing medical science.